Schechter Investment Advisors, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

Back to all holdings Add to watchlist

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Schechter Investment Advisors, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$792,000
+4.3%
79,060
+3.2%
0.08%
+5.4%
Q2 2022$759,000
-7.0%
76,642
-7.4%
0.07%
-2.6%
Q1 2022$816,000
-6.4%
82,802
-5.3%
0.08%
-3.8%
Q4 2021$872,000–87,392–0.08%–
 Download
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,578,7491.28%
Verition Fund Management LLC 397,603$4,115,1910.06%
CLEAR STREET LLC 2,740$280.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1$100.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders